As part of our continued advocacy efforts, AATB—alongside AOPO and EBAA—sent a joint letter today to newly confirmed FDA Commissioner Dr. Marty Makary urging the immediate rescission of two guidance documents issued as final on January 6, 2025.

Join industry professionals from blood centers, tissue banks, and organ procurement organizations across the country for two days of valuable networking, knowledge-sharing, and collaboration.

AATB commends Representatives John Moolenaar (R-MI) and Debbie Dingell (D-MI) for reintroducing the Shandra Eisenga Human Cell and Tissue Product Safety Act, a vital piece of legislation aimed at preventing tuberculosis (TB) infections linked to tissue transplants.

Mark your calendars for the 2025 AATB Annual Meeting, which will take place October 12-15, 2025, in Atlanta, GA. This must-attend event will bring together professionals from across the tissue donation and transplantation community to connect, innovate, and advance meaningful progress.

Earlier this week, AATB representatives and members had the incredible opportunity to visit Capitol Hill, to advocate for key issues impacting the tissue banking community.

AATB is pleased to announce that we will no longer charge institutional members a supplemental fee for satellite site inspections conducted as part of the routine three-year accreditation cycle. 

The FDA has announced a revised implementation date of May 4, 2025, for its recently issued guidance documents.

On Friday, January 24, 2025, all seven Medicare Administrative Contractors (MACs) announced a delay in implementing final skin substitute Local Coverage Determinations (LCDs). Initially set to take effect on February 12, 2025, the implementation date has been postponed to April 13, 2025.

In light of recent regulatory developments, it is essential for stakeholders in the tissue banking community to stay informed about potential changes to FDA guidance documents.